In vitro interaction between amphotericin B and azoles in Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2511-2516

  Vazquez, Jose A ^a,b,c   Arganoza, Maria T ^a   Vaishampayan, Julie K ^a   Akins, Robert A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Harper Professional Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS GROWTH; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0029926514     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2511     Document Type: Article

References (45)

1. Barchiesi, F., A. L. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J. Clin. Microbiol. 32:2494-2500.
2. Bastide, M., S. Jouvert, and J. M. Bastide. 1982. A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy. Can. J. Microbiol. 28:1119-1126.
3. Ben-Yaacov, R., S. Knoller, G. Caldwell, J. M. Becker, and Y. Koltin. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:648-652.
4. Brajtburg, J., D. Kobayashi, G. Medoff, and G. S. Kobayashi. 1982 Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. J. Infect. Dis. 146:138-146.
5. Cassone, A., D. Kerridge, and E. F. Gale. 1979. Ultrastructural changes in the cell wall of Candida albicans following the cessation of growth and their possible relationship to the development of polyene resistance. J. Gen. Microbiol. 110:339-349.
6. Chalkley, L. J., A. P. J. Trinci, and A. M. S. Pope. 1985. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro. Sabouraudia J. Med. Vet. Mycol. 23:147-164.
7. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. A. R. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 40:419-425.
8. Cosgrove, R. F., A. E. Beezer, and R. J. Miles. 1978. In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole. J. Infect. Dis. 138:681-685.
9. Crombie, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
10. De Nollin, S., and M. Borgers. 1974. The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia 12:341-351.
11. De Nollin, S., and M. Borgers. 1975. Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob. Agents Chemother. 7:704-711.
12. Fling, M. E., J. Kopf, A. Tamarkin, J. A. Gorman, H. A. Smith, and Y. Koltin. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-327.
13. Gale, E. F. 1986. Nature and development of phenotypic resistance to amphotericin B in stationary phase cultures of Candida albicans. Adv. Microbiol. Physiol. 27:277-230.
14. Gale, E. F., J. Ingram, D. Kerridge, V. Notario, and F. Wayman. 1980. Reduction of amphotericin B resistance in stationary phase cultures of Candida albicans by treatment with enzymes. J. Gen. Microbiol. 117:383-391.
15. Gale, E. F., A. M. Johnson, K. Kerridge, and T. Y. Koh. 1975. Factors affecting the changes in amphotericin B sensitivity of Candida albicans during growth. J. Gen. Microbiol. 87:20-36.
16. Gale, E. F., A. M. Johnson, K. Kerridge, and F. Wayman. 1980. Phenotypic resistance to miconazole and amphotericin B in Candida albicans. J. Gen. Microbiol. 117:535-538.
17. Gallis, H. A., R. H. Drew, and W. W. Pickerd. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-328.
18. Geber, A., C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon Chung, and J. E. Bennett. 1995. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents Chemother. 39: 2708-2717.
19. Ghannoum, M. A., Y. Fu, A. S. Ibrahim, L. A. Mortara, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1995. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicrob. Agents Chemother. 39:2459-2465.
20. Ghannoum, M. A., J. H. Rex, and J. N. Galgiani. 1996. Susceptibility testing of fungi: current status of correlation of in vitro data and clinical outcome. J. Clin. Microbiol. 34:489-495.
21. Goldway, M., D. Teff, R. Schmidt, A. B. Oppenheim, and Y. Koltin. 1995. Multidrug resistance in Candida albicans: disruption of the BENr gene. Antimicrob. Agents Chemother. 39:422-426.
22. Hughes, C. E., C. Harris, J. A. Moody, L. R. Peterson, and D. N. Gerding. 1984. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp. Antimicrob. Agents Chemother. 25:560-562.
23. Martin, E., F. Maier, and S. Bhakdi. 1994. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Antimicrob. Agents Chemother. 38:1331-1338.
24. Mikami, Y., G. M. Scalarone, N. Kurita, K. Yazawa, J. Uno, and M. Miyaji. 1992. Synergistic post antifungal effect of flucytosine and fluconazole on Candida albicans. J. Med. Vet. Mycol. 30:197-206.
25. Mikami, Y., A. Takahashi, K. Yazawa, K. Terao, and Y. Ueno. 1992. Synergistic interaction of miconazole and fluconazole at sub-MIC level on Candida albicans. Mycoses 35:321-327.
26. Notario, V., E. F. Gale, D. Kerridge, and F. Wayman. 1982. Phenotypic resistance to amphotericin B in Candida albicans: relationship to glucan metabolism. J. Gen. Microbiol. 128:761-777.
27. Odds, F. C. 1982. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrob. Agents Chemother. 22:763-770.
28. Polak, A. 1990. Mode of action studies, p. 155-181. In F. Ryley (ed.), Chemotherapy of fungal diseases. Springet-Verlag KG, Berlin.
29. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
30. Safe, L. M., S. H. Safe, R. E. Subden, and D. C. Morris. 1977. Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. Can. J. Microbiol. 23:398-401.
31. Sanglard, D., K. Kuchler, F. Fisher, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
32. Scalarone, G. M., Y. Mikami, K. Yazawa, and M. Miyaji. 1992. Comparative studies on the post antifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans. Mycopathologia 120:133-138.
33. Schacter, L. P., R. J. Owellen, H. K. Rathbun, and B. Buchanan. 1976. Antagonism between miconazole and amphotericin B. Lancet ii:318.
34. Schaffner, A., and A. Bohler. 1993. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism. Mycoses 36:421-424.
35. Scheven, M., and M. L. Scheven. 1995. Interaction between azoles and amphotericin B in the treatment of candidiasis. Clin. Infect. Dis. 20:1079.
36. Scheven, M., and F. Schwegler. 1995. Antagonistic interactions between azoles and amphotericin B with yeast depend on azole lipophilic for special test conditions in vitro. Antimicrob. Agents Chemother. 39:1779-1783.
37. Scheven, M., and L. Senf. 1994. Quantitative determination of fluconazole amphotericin B antagonism to Candida albicans by agar diffusion. Mycoses 37:205-207.
38. Shadomy, S., A. Espinel-Ingroff, and R. Y. Cartwright. 1985. Laboratory studies with antifungal agents: susceptibility tests and bioassays, p. 991-999. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
39. Shimokawa, O., and H. Nakayama. 1992. Increased sensitivity of Candida albicans cells accumulating 14a-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob. Agents Chemother. 36:1626-1629.
40. Smith, H. A., W. Gorman, Y. Koltin, and J. A. Gorman. 1990. Functional overexpression of the Candida albicans β-tubulin gene in Saccharomyces cerevisiae. Gene 90:115-123.
41. Sud, I. J., and D. S. Feingold. 1983. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Antimicrob. Agents Chemother. 23:185-187.
42. Sugar, A. M. 1995. Use of amphotericin B with azole antifungal drugs: what are we doing? Antimicrob. Agents Chemother. 39:1907-1912.
43. Van Etten, E. W. M., N. E. Van De Rhee, K. M. Van Kampen, and I. A. J. M. Bakker-Woudenberg. 1991. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans. Antimicrob. Agents Chemother. 35:2275-2281.
44. Watson, P. F., M. E. Rose, and S. L. Kelly. 1988. Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae. J. Med. Vet. Mycol. 26:153-162.
45. Woods, R. A., M. Bard, I. E. Jackson, and D. J. Drutz. 1974. Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. J. Infect. Dis. 129:53-58.